Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...

If you’ve experienced a heart attack, your healthcare provider may prescribe certain medications to help prevent one from ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Novo Nordisk’s obesity drug Wegovy is now recommended by EU regulatory authorities for obesity-related heart conditions.

Cambridge-based CardiaTec has raised $6.5mn for its AI-based drug discovery platform for cardiovascular diseases.

The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...

Edgewise Therapeutics's hypertrophic cardiomyopathy (HCM) asset has started off with a bang after early safety data sent the ...

They concluded that I had a mild heart attack called a non-ST-elevation myocardial infarction (NSTEMI) due to COVID. How is ...

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

These and other metals found in the environment can collect in the body and exacerbate heart disease, new research suggests.